Grifols News and Biopharmaceuticals & Plasma Medicines Updates

  • Mykhailo Ihnatenko
  • 10.06.2026
Grifols recovery hinges on debt reduction
​Grifols shares remain under pressure following a challenging two-year period, although the company's fundamental outlook is gradually improving. The business continues to grow earnings while ...